Development and Validation of Harbinger Health Test for Early Cancer Detection

Inclusion Criteria: * Inclusion Criteria - Both arms Subjects must meet the following criteria in order to be included in the research study: * Written or electronic informed consent * Subject is 20 - 79 years of age at the time of signature of the informed consent form (ICF) * Male or female subjects Inclusion Criteria Arm 1 - Cancer Subjects Arm 1 subjects enrolled in the study must meet the following inclusion criteria. * A confirmed diagnosis or high suspicion of cancer (stage I to IV solid cancer or hematologic cancer) by imaging within 180 days prior to enrollment; not to include myelodysplastic and myeloproliferative syndromes * Subject's cancer diagnosis is based upon assessment of a pathological specimen or high suspicion of cancer by imaging * Subject's cancer is treatment-naïve Inclusion Criteria Arm 2 - Non-Cancer Subjects (All Cohorts) Arm 2 subjects enrolled in the study must meet the following inclusion criteria: * Subject's health permits participation and the subject is not suspected of having cancer based on provider assessment. * The subject was not diagnosed with cancer or received cancer treatment within the last 5 years (persons with completely resected ductal carcinoma in-situ or non-melanoma skin cancer are permitted). Part 1B Only : \- Subject has no known current cancer and has 1 of the follow conditions: o An Advanced Adenoma (AA) of the gastrointestinal tract as defined as an adenoma that is ≤10mm in size Subjects with any one of the cri…